학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 33건 | 목록 1~10
Academic Journal
Ochenduszko S; Hospital Universitario Doctor Peset, Valencia, Spain.; García Sanchez J; Centre Hospitalier de Wallonie Picarde, Tournai, Belgium.; Fita MJJ; Instituto Valenciano de Oncología, Valencia, Spain.; González-Barrallo I; Hospital Clínico Universitario de Valencia. INCLIVA, Valencia, Spain.; Herrero Colomina J; Unidad del Cáncer de Gipuzkoa, OSID-Onkologikoa, San Sebastian, Spain.; Mujika K; Unidad del Cáncer de Gipuzkoa, OSID-Onkologikoa, San Sebastian, Spain.; Beveridge RD; Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Martínez SR; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.; Lafuente BS; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.; Tomas AC; Consorcio Hospital General Universitario de Valencia, Hospital General de Requena, Requena, Spain.; Jaime AB; Consorcio Hospital General Universitario de Valencia, Valencia, Spain.; Cerezuela Fuentes P; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.; Fra PL; Hospital Universitari Son Espases, Palma, Spain.; Peeters AG; Hospital Universitari Son Espases, Palma, Spain.; Meana García JA; Hospital General Universitario de Alicante, Alicante, Spain.; García MAA; Hospital Marina Baixa, Villajoyosa, Spain.; Altozano JP; Hospital Virgen de los Lirios, Alcoy, Spain.; Cancela M; Hospital Virgen de los Lirios, Alcoy, Spain.; Puchades AM; Hospital Universitario Doctor Peset, Valencia, Spain.; Roca FF; Hospital Universitario Doctor Peset, Valencia, Spain.; Maiques IM; Hospital Universitario Doctor Peset, Valencia, Spain.
Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-148X (Electronic) Linking ISSN: 17551471 NLM ISO Abbreviation: Pigment Cell Melanoma Res Subsets: MEDLINE
Academic Journal
Gonzalez-Cao M; Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, C/Sabino Arana, 5, 080028, Barcelona, Spain. mgonzalezcao@oncorosell.com.; Puertolas T; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Martinez-Vila C; Fundación Althaia, Xarxa Assistencial Universitària de Manresa, Barcelona, Spain.; Carrera C; Dermatology Department, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melanoma Group IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.; Maldonado Seral C; Hospital Universitario Central de Asturias, Oviedo, Spain.; Rodríguez-Jiménez P; Dermatology Department, Hospital Universitario la Princesa, Madrid, Spain.; Sequero S; Medical Oncology Department, Hospital San Cecilio, Granada, Spain.; Cerezuela-Fuentes P; Medical Oncology Department, Hospital Clinico Universitario Virgen Arrixaca, Murcia, Spain.; Feltes Ochoa R; Hospital Universitario la Paz, Madrid, Spain.; Muñoz E; Medical Oncology Department. Hospital, Universitari Vall d'Hebron, Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Antoñanzas Basa M; Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain.; Martín-Liberal J; Medical Oncology Department, Catalan Institute of Oncology (ICO) Hospitalet, Barcelona, Spain.; Soria A; Medical Oncology Department, Hospital Ramon y Cajal, Madrid, Spain.; Francisco Rodriguez Moreno J; Medical Oncology Department, Centro Integral Oncologico HM Clara Campal, Madrid, Spain.; Marquez-Rodas I; Medical Oncology Department, Hospital General Universitario Gregorio Marañon and CIBERONC, Madrid, Spain.; Lopez Criado P; Medical Oncology Department, Hospital MD Anderson, Madrid, Spain.; Luis Manzano J; Medical Oncology Department, Catalonian Institute of Oncology (ICO-Badalona), Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Barcelona, Spain.; Lopez-Castro R; Medical Oncology Department, HCU Valladolid, Valladolid, Spain.; Ayala de Miguel P; Hospital San Pedro de Alcántara, Cáceres, Spain.; Villalobos L; Hospital Principe de Asturias, Alcala de Henares, Spain.; Martin Algarra S; Medical Oncology Department, Clinica Universitaria de Navarra, Pamplona, Spain.; Gonzalez-Barrallo I; Hospital Clinico de Valencia, Valencia, Spain.; Boada A; Dermatology Department, Hospital Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Barcelona, Spain.; García Castaño A; Medical Oncology Department, Hospital Marqués de Valdecilla, Santander, Spain.; Puig S; Dermatology Department, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melanoma Group IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.; Crespo G; Hospital Universitario de Burgos, Burgos, Spain.; Luna Fra P; Hospital Son Espases, Mallorca, Spain.; Aguayo Zamora C; Hospital Universitario Infanta Sofía, Madrid, Spain.; Feito Rodríguez M; Hospital Universitario la Paz, Madrid, Spain.; Valles L; Hospital General de Villalba, Madrid, Spain.; Drozdowskyj A; Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, C/Sabino Arana, 5, 080028, Barcelona, Spain.; Gardeazabal J; Hospital de Cruces, Bilbao, Spain.; Antonio Fernandez-Morales L; Hospital Parc Tauli, Sabadell, Spain.; Rodrigo A; Hospital Arnau de Vilanova, Lleida, Spain.; Cruz R; Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.; Yelamos O; Dermatology Department, Hospital Sant Pau, Barcelona, Spain.; Rubio B; Oncology Department, Hospital Quiron, Madrid, Spain.; Mujica K; Hospital Donostia, Donostia, Spain.; Provencio M; Hospital Puerta de Hierro, Madrid, Spain.; Berrocal A; Hospital Universitario General de Valencia, Valencia, Spain.
Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Academic Journal
González-Barrallo I; Oncology Department, Hospital Clínico Universitario de Valencia, Valencia.; Castellón Rubio VE; Department of Medical Oncology, Hospital Universitario Torrecárdenas, Almería.; Medina J; Division of Medical Oncology, Virgen de la Salud Hospital, Toledo.; España S; Medical Oncology Service, Catalan Institute of Oncology (ICO), Germans Trias i Pujol University Hospital, Barcelona.; Health Sciences Research Institute of the Germans Trias i Pujol Foundation (IGTP), Badalona.; Mujika K; Medical Oncology Department, UGC de Oncología de Gipuzkoa, Hospital Universitario de Donostia - Onkologikoa, Gipuzkoa.; Majem M; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona.; Aguado C; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid.; Cabrera Suárez MÁ; Medical Oncology Department, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife.; Palacio I; Medical Oncology, Hospital Universitario Central de Asturias, Oviedo.; Osterloh L; Medical Department, Novartis Farmacéutica, S.A., Barcelona.; Martínez-Fernández A; Medical Department, Novartis Farmacéutica, S.A., Barcelona.; García-Castaño A; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5636 (Electronic) Linking ISSN: 09608931 NLM ISO Abbreviation: Melanoma Res Subsets: MEDLINE
Academic Journal
Gambardella V; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Lombardi P; Division of Medical Oncology, Institute for Cancer Research and Treatment, IRCCS Candiolo, Candiolo, Italy.; Carbonell-Asins JA; Bioinformatic and Biostatistic Unit, INCLIVA Biomedical Research Institute, Valencia, Spain.; Tarazona N; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Cejalvo JM; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; González-Barrallo I; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Martín-Arana J; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Bioinformatic and Biostatistic Unit, INCLIVA Biomedical Research Institute, Valencia, Spain.; Tébar-Martínez R; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Precision Medicine Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Translational Oncology Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Viala A; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Bruixola G; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Hernando C; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Blasco I; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Papaccio F; Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi, SA, Italy.; Martínez-Ciarpaglini C; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Alfaro-Cervelló C; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Seda-García E; Precision Medicine Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Translational Oncology Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Blesa S; Precision Medicine Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Translational Oncology Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Chirivella I; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Castillo J; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Biochemistry and Molecular Biology, University of Valencia, Valencia, Spain.; Montón-Bueno JV; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Roselló S; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Huerta M; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Pérez-Fidalgo A; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Martín-Martorell P; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Insa-Mollá A; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Fleitas T; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Rentero-Garrido P; Precision Medicine Unit, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Zúñiga-Trejos S; Bioinformatic and Biostatistic Unit, INCLIVA Biomedical Research Institute, Valencia, Spain.; Cervantes A; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain. andres.cervantes@uv.es.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. andres.cervantes@uv.es.; Roda D; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. droda@incliva.es.; Division of Medical Oncology, Institute for Cancer Research and Treatment, IRCCS Candiolo, Candiolo, Italy. droda@incliva.es.
Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Report
Gambardella V; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Cejalvo JM; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; González-Barrallo I; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Gimeno-Valiente F; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; University College London School of Life and Medical Sciences, Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cervantes A; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: andres.cervantes@uv.es.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: PubMed not MEDLINE; MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Gonzalez-Barrallo, I.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어